Global Post-Traumatic Stress Disorder (PTSD) Market Growth (Status and Outlook) 2025-2031
According to this study, the global Post-Traumatic Stress Disorder (PTSD) market size will reach US$ million by 2031.
Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened.The incidence of PTSD has been reported inconsistently, with women more likely to develop PTSD than men.
United States market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Post-Traumatic Stress Disorder (PTSD) players cover GlaxoSmithKline (UK), Pfizer (US), Eli Lilly and Company (US), Lundbeck A/S (Denmark), Azevan Pharmaceuticals (US), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Post-Traumatic Stress Disorder (PTSD) Industry Forecast” looks at past sales and reviews total world Post-Traumatic Stress Disorder (PTSD) sales in 2024, providing a comprehensive analysis by region and market sector of projected Post-Traumatic Stress Disorder (PTSD) sales for 2025 through 2031. With Post-Traumatic Stress Disorder (PTSD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Post-Traumatic Stress Disorder (PTSD) industry.
This Insight Report provides a comprehensive analysis of the global Post-Traumatic Stress Disorder (PTSD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Post-Traumatic Stress Disorder (PTSD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Post-Traumatic Stress Disorder (PTSD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Post-Traumatic Stress Disorder (PTSD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Post-Traumatic Stress Disorder (PTSD).
This report presents a comprehensive overview, market shares, and growth opportunities of Post-Traumatic Stress Disorder (PTSD) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened.The incidence of PTSD has been reported inconsistently, with women more likely to develop PTSD than men.
United States market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Post-Traumatic Stress Disorder (PTSD) players cover GlaxoSmithKline (UK), Pfizer (US), Eli Lilly and Company (US), Lundbeck A/S (Denmark), Azevan Pharmaceuticals (US), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Post-Traumatic Stress Disorder (PTSD) Industry Forecast” looks at past sales and reviews total world Post-Traumatic Stress Disorder (PTSD) sales in 2024, providing a comprehensive analysis by region and market sector of projected Post-Traumatic Stress Disorder (PTSD) sales for 2025 through 2031. With Post-Traumatic Stress Disorder (PTSD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Post-Traumatic Stress Disorder (PTSD) industry.
This Insight Report provides a comprehensive analysis of the global Post-Traumatic Stress Disorder (PTSD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Post-Traumatic Stress Disorder (PTSD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Post-Traumatic Stress Disorder (PTSD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Post-Traumatic Stress Disorder (PTSD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Post-Traumatic Stress Disorder (PTSD).
This report presents a comprehensive overview, market shares, and growth opportunities of Post-Traumatic Stress Disorder (PTSD) market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cognitive Therapy
- Exposure Therapy
- Eye Movement Desensitization And Reprocessing (EMDR)
- Antidepressants
- Anti-Anxiety Medications
- Prazosin
- Children
- Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline (UK)
- Pfizer (US)
- Eli Lilly and Company (US)
- Lundbeck A/S (Denmark)
- Azevan Pharmaceuticals (US)
- Marinus Pharmaceuticals, Inc. (US)
- Tonix Pharmaceuticals Holding Corp. (US)
- Bionomics (Australia)
- Greenstone LLC (US)
- Mylan NV (US)
- Otsuka Pharmaceutical (Japan)
- Prometheon Pharma (USA)
- Ligand Pharma (USA)
- Valenta Pharm (Russia)
- Lycera Corp (US)
- Archimedes (UK)
- GMP Endotherapeutics (USA)
- Nuvo Pharmaceuticals (Canada)
- Beijing Wansheng Pharmaceutical
- Zhejiang Huahai Pharmaceutical
- Zhejiang Jianfeng Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size (2020-2031)
2.1.2 Post-Traumatic Stress Disorder (PTSD) Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Post-Traumatic Stress Disorder (PTSD) by Country/Region (2020, 2024 & 2031)
2.2 Post-Traumatic Stress Disorder (PTSD) Segment by Type
2.2.1 Cognitive Therapy
2.2.2 Exposure Therapy
2.2.3 Eye Movement Desensitization And Reprocessing (EMDR)
2.2.4 Antidepressants
2.2.5 Anti-Anxiety Medications
2.2.6 Prazosin
2.3 Post-Traumatic Stress Disorder (PTSD) Market Size by Type
2.3.1 Post-Traumatic Stress Disorder (PTSD) Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2020-2025)
2.4 Post-Traumatic Stress Disorder (PTSD) Segment by Application
2.4.1 Children
2.4.2 Adult
2.5 Post-Traumatic Stress Disorder (PTSD) Market Size by Application
2.5.1 Post-Traumatic Stress Disorder (PTSD) Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2020-2025)
3 POST-TRAUMATIC STRESS DISORDER (PTSD) MARKET SIZE BY PLAYER
3.1 Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Player
3.1.1 Global Post-Traumatic Stress Disorder (PTSD) Revenue by Player (2020-2025)
3.1.2 Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Player (2020-2025)
3.2 Global Post-Traumatic Stress Disorder (PTSD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 POST-TRAUMATIC STRESS DISORDER (PTSD) BY REGION
4.1 Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2020-2025)
4.2 Global Post-Traumatic Stress Disorder (PTSD) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Post-Traumatic Stress Disorder (PTSD) Market Size Growth (2020-2025)
4.4 APAC Post-Traumatic Stress Disorder (PTSD) Market Size Growth (2020-2025)
4.5 Europe Post-Traumatic Stress Disorder (PTSD) Market Size Growth (2020-2025)
4.6 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025)
5.2 Americas Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025)
5.3 Americas Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2020-2025)
6.2 APAC Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025)
6.3 APAC Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025)
7.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025)
7.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) by Region (2020-2025)
8.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025)
8.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL POST-TRAUMATIC STRESS DISORDER (PTSD) MARKET FORECAST
10.1 Global Post-Traumatic Stress Disorder (PTSD) Forecast by Region (2026-2031)
10.1.1 Global Post-Traumatic Stress Disorder (PTSD) Forecast by Region (2026-2031)
10.1.2 Americas Post-Traumatic Stress Disorder (PTSD) Forecast
10.1.3 APAC Post-Traumatic Stress Disorder (PTSD) Forecast
10.1.4 Europe Post-Traumatic Stress Disorder (PTSD) Forecast
10.1.5 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Forecast
10.2 Americas Post-Traumatic Stress Disorder (PTSD) Forecast by Country (2026-2031)
10.2.1 United States Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.2.2 Canada Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.2.3 Mexico Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.2.4 Brazil Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.3 APAC Post-Traumatic Stress Disorder (PTSD) Forecast by Region (2026-2031)
10.3.1 China Post-Traumatic Stress Disorder (PTSD) Market Forecast
10.3.2 Japan Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.3.3 Korea Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.3.4 Southeast Asia Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.3.5 India Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.3.6 Australia Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.4 Europe Post-Traumatic Stress Disorder (PTSD) Forecast by Country (2026-2031)
10.4.1 Germany Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.4.2 France Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.4.3 UK Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.4.4 Italy Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.4.5 Russia Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.5 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Forecast by Region (2026-2031)
10.5.1 Egypt Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.5.2 South Africa Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.5.3 Israel Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.5.4 Turkey Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.6 Global Post-Traumatic Stress Disorder (PTSD) Forecast by Type (2026-2031)
10.7 Global Post-Traumatic Stress Disorder (PTSD) Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Post-Traumatic Stress Disorder (PTSD) Forecast
11 KEY PLAYERS ANALYSIS
11.1 GlaxoSmithKline (UK)
11.1.1 GlaxoSmithKline (UK) Company Information
11.1.2 GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.1.3 GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 GlaxoSmithKline (UK) Main Business Overview
11.1.5 GlaxoSmithKline (UK) Latest Developments
11.2 Pfizer (US)
11.2.1 Pfizer (US) Company Information
11.2.2 Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.2.3 Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Pfizer (US) Main Business Overview
11.2.5 Pfizer (US) Latest Developments
11.3 Eli Lilly and Company (US)
11.3.1 Eli Lilly and Company (US) Company Information
11.3.2 Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.3.3 Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Eli Lilly and Company (US) Main Business Overview
11.3.5 Eli Lilly and Company (US) Latest Developments
11.4 Lundbeck A/S (Denmark)
11.4.1 Lundbeck A/S (Denmark) Company Information
11.4.2 Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.4.3 Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Lundbeck A/S (Denmark) Main Business Overview
11.4.5 Lundbeck A/S (Denmark) Latest Developments
11.5 Azevan Pharmaceuticals (US)
11.5.1 Azevan Pharmaceuticals (US) Company Information
11.5.2 Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.5.3 Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Azevan Pharmaceuticals (US) Main Business Overview
11.5.5 Azevan Pharmaceuticals (US) Latest Developments
11.6 Marinus Pharmaceuticals, Inc. (US)
11.6.1 Marinus Pharmaceuticals, Inc. (US) Company Information
11.6.2 Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.6.3 Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Marinus Pharmaceuticals, Inc. (US) Main Business Overview
11.6.5 Marinus Pharmaceuticals, Inc. (US) Latest Developments
11.7 Tonix Pharmaceuticals Holding Corp. (US)
11.7.1 Tonix Pharmaceuticals Holding Corp. (US) Company Information
11.7.2 Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.7.3 Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Tonix Pharmaceuticals Holding Corp. (US) Main Business Overview
11.7.5 Tonix Pharmaceuticals Holding Corp. (US) Latest Developments
11.8 Bionomics (Australia)
11.8.1 Bionomics (Australia) Company Information
11.8.2 Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.8.3 Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Bionomics (Australia) Main Business Overview
11.8.5 Bionomics (Australia) Latest Developments
11.9 Greenstone LLC (US)
11.9.1 Greenstone LLC (US) Company Information
11.9.2 Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.9.3 Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Greenstone LLC (US) Main Business Overview
11.9.5 Greenstone LLC (US) Latest Developments
11.10 Mylan NV (US)
11.10.1 Mylan NV (US) Company Information
11.10.2 Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.10.3 Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Mylan NV (US) Main Business Overview
11.10.5 Mylan NV (US) Latest Developments
11.11 Otsuka Pharmaceutical (Japan)
11.11.1 Otsuka Pharmaceutical (Japan) Company Information
11.11.2 Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.11.3 Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Otsuka Pharmaceutical (Japan) Main Business Overview
11.11.5 Otsuka Pharmaceutical (Japan) Latest Developments
11.12 Prometheon Pharma (USA)
11.12.1 Prometheon Pharma (USA) Company Information
11.12.2 Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.12.3 Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Prometheon Pharma (USA) Main Business Overview
11.12.5 Prometheon Pharma (USA) Latest Developments
11.13 Ligand Pharma (USA)
11.13.1 Ligand Pharma (USA) Company Information
11.13.2 Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.13.3 Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Ligand Pharma (USA) Main Business Overview
11.13.5 Ligand Pharma (USA) Latest Developments
11.14 Valenta Pharm (Russia)
11.14.1 Valenta Pharm (Russia) Company Information
11.14.2 Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.14.3 Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Valenta Pharm (Russia) Main Business Overview
11.14.5 Valenta Pharm (Russia) Latest Developments
11.15 Lycera Corp (US)
11.15.1 Lycera Corp (US) Company Information
11.15.2 Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.15.3 Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Lycera Corp (US) Main Business Overview
11.15.5 Lycera Corp (US) Latest Developments
11.16 Archimedes (UK)
11.16.1 Archimedes (UK) Company Information
11.16.2 Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.16.3 Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Archimedes (UK) Main Business Overview
11.16.5 Archimedes (UK) Latest Developments
11.17 GMP Endotherapeutics (USA)
11.17.1 GMP Endotherapeutics (USA) Company Information
11.17.2 GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.17.3 GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 GMP Endotherapeutics (USA) Main Business Overview
11.17.5 GMP Endotherapeutics (USA) Latest Developments
11.18 Nuvo Pharmaceuticals (Canada)
11.18.1 Nuvo Pharmaceuticals (Canada) Company Information
11.18.2 Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.18.3 Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Nuvo Pharmaceuticals (Canada) Main Business Overview
11.18.5 Nuvo Pharmaceuticals (Canada) Latest Developments
11.19 Beijing Wansheng Pharmaceutical
11.19.1 Beijing Wansheng Pharmaceutical Company Information
11.19.2 Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product Offered
11.19.3 Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Beijing Wansheng Pharmaceutical Main Business Overview
11.19.5 Beijing Wansheng Pharmaceutical Latest Developments
11.20 Zhejiang Huahai Pharmaceutical
11.20.1 Zhejiang Huahai Pharmaceutical Company Information
11.20.2 Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product Offered
11.20.3 Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Zhejiang Huahai Pharmaceutical Main Business Overview
11.20.5 Zhejiang Huahai Pharmaceutical Latest Developments
11.21 Zhejiang Jianfeng Pharmaceutical
11.21.1 Zhejiang Jianfeng Pharmaceutical Company Information
11.21.2 Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product Offered
11.21.3 Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Zhejiang Jianfeng Pharmaceutical Main Business Overview
11.21.5 Zhejiang Jianfeng Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size (2020-2031)
2.1.2 Post-Traumatic Stress Disorder (PTSD) Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Post-Traumatic Stress Disorder (PTSD) by Country/Region (2020, 2024 & 2031)
2.2 Post-Traumatic Stress Disorder (PTSD) Segment by Type
2.2.1 Cognitive Therapy
2.2.2 Exposure Therapy
2.2.3 Eye Movement Desensitization And Reprocessing (EMDR)
2.2.4 Antidepressants
2.2.5 Anti-Anxiety Medications
2.2.6 Prazosin
2.3 Post-Traumatic Stress Disorder (PTSD) Market Size by Type
2.3.1 Post-Traumatic Stress Disorder (PTSD) Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2020-2025)
2.4 Post-Traumatic Stress Disorder (PTSD) Segment by Application
2.4.1 Children
2.4.2 Adult
2.5 Post-Traumatic Stress Disorder (PTSD) Market Size by Application
2.5.1 Post-Traumatic Stress Disorder (PTSD) Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2020-2025)
3 POST-TRAUMATIC STRESS DISORDER (PTSD) MARKET SIZE BY PLAYER
3.1 Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Player
3.1.1 Global Post-Traumatic Stress Disorder (PTSD) Revenue by Player (2020-2025)
3.1.2 Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Player (2020-2025)
3.2 Global Post-Traumatic Stress Disorder (PTSD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 POST-TRAUMATIC STRESS DISORDER (PTSD) BY REGION
4.1 Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2020-2025)
4.2 Global Post-Traumatic Stress Disorder (PTSD) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Post-Traumatic Stress Disorder (PTSD) Market Size Growth (2020-2025)
4.4 APAC Post-Traumatic Stress Disorder (PTSD) Market Size Growth (2020-2025)
4.5 Europe Post-Traumatic Stress Disorder (PTSD) Market Size Growth (2020-2025)
4.6 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025)
5.2 Americas Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025)
5.3 Americas Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2020-2025)
6.2 APAC Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025)
6.3 APAC Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025)
7.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025)
7.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) by Region (2020-2025)
8.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025)
8.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL POST-TRAUMATIC STRESS DISORDER (PTSD) MARKET FORECAST
10.1 Global Post-Traumatic Stress Disorder (PTSD) Forecast by Region (2026-2031)
10.1.1 Global Post-Traumatic Stress Disorder (PTSD) Forecast by Region (2026-2031)
10.1.2 Americas Post-Traumatic Stress Disorder (PTSD) Forecast
10.1.3 APAC Post-Traumatic Stress Disorder (PTSD) Forecast
10.1.4 Europe Post-Traumatic Stress Disorder (PTSD) Forecast
10.1.5 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Forecast
10.2 Americas Post-Traumatic Stress Disorder (PTSD) Forecast by Country (2026-2031)
10.2.1 United States Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.2.2 Canada Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.2.3 Mexico Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.2.4 Brazil Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.3 APAC Post-Traumatic Stress Disorder (PTSD) Forecast by Region (2026-2031)
10.3.1 China Post-Traumatic Stress Disorder (PTSD) Market Forecast
10.3.2 Japan Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.3.3 Korea Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.3.4 Southeast Asia Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.3.5 India Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.3.6 Australia Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.4 Europe Post-Traumatic Stress Disorder (PTSD) Forecast by Country (2026-2031)
10.4.1 Germany Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.4.2 France Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.4.3 UK Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.4.4 Italy Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.4.5 Russia Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.5 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Forecast by Region (2026-2031)
10.5.1 Egypt Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.5.2 South Africa Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.5.3 Israel Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.5.4 Turkey Market Post-Traumatic Stress Disorder (PTSD) Forecast
10.6 Global Post-Traumatic Stress Disorder (PTSD) Forecast by Type (2026-2031)
10.7 Global Post-Traumatic Stress Disorder (PTSD) Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Post-Traumatic Stress Disorder (PTSD) Forecast
11 KEY PLAYERS ANALYSIS
11.1 GlaxoSmithKline (UK)
11.1.1 GlaxoSmithKline (UK) Company Information
11.1.2 GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.1.3 GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 GlaxoSmithKline (UK) Main Business Overview
11.1.5 GlaxoSmithKline (UK) Latest Developments
11.2 Pfizer (US)
11.2.1 Pfizer (US) Company Information
11.2.2 Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.2.3 Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Pfizer (US) Main Business Overview
11.2.5 Pfizer (US) Latest Developments
11.3 Eli Lilly and Company (US)
11.3.1 Eli Lilly and Company (US) Company Information
11.3.2 Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.3.3 Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Eli Lilly and Company (US) Main Business Overview
11.3.5 Eli Lilly and Company (US) Latest Developments
11.4 Lundbeck A/S (Denmark)
11.4.1 Lundbeck A/S (Denmark) Company Information
11.4.2 Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.4.3 Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Lundbeck A/S (Denmark) Main Business Overview
11.4.5 Lundbeck A/S (Denmark) Latest Developments
11.5 Azevan Pharmaceuticals (US)
11.5.1 Azevan Pharmaceuticals (US) Company Information
11.5.2 Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.5.3 Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Azevan Pharmaceuticals (US) Main Business Overview
11.5.5 Azevan Pharmaceuticals (US) Latest Developments
11.6 Marinus Pharmaceuticals, Inc. (US)
11.6.1 Marinus Pharmaceuticals, Inc. (US) Company Information
11.6.2 Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.6.3 Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Marinus Pharmaceuticals, Inc. (US) Main Business Overview
11.6.5 Marinus Pharmaceuticals, Inc. (US) Latest Developments
11.7 Tonix Pharmaceuticals Holding Corp. (US)
11.7.1 Tonix Pharmaceuticals Holding Corp. (US) Company Information
11.7.2 Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.7.3 Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Tonix Pharmaceuticals Holding Corp. (US) Main Business Overview
11.7.5 Tonix Pharmaceuticals Holding Corp. (US) Latest Developments
11.8 Bionomics (Australia)
11.8.1 Bionomics (Australia) Company Information
11.8.2 Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.8.3 Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Bionomics (Australia) Main Business Overview
11.8.5 Bionomics (Australia) Latest Developments
11.9 Greenstone LLC (US)
11.9.1 Greenstone LLC (US) Company Information
11.9.2 Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.9.3 Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Greenstone LLC (US) Main Business Overview
11.9.5 Greenstone LLC (US) Latest Developments
11.10 Mylan NV (US)
11.10.1 Mylan NV (US) Company Information
11.10.2 Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.10.3 Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Mylan NV (US) Main Business Overview
11.10.5 Mylan NV (US) Latest Developments
11.11 Otsuka Pharmaceutical (Japan)
11.11.1 Otsuka Pharmaceutical (Japan) Company Information
11.11.2 Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.11.3 Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Otsuka Pharmaceutical (Japan) Main Business Overview
11.11.5 Otsuka Pharmaceutical (Japan) Latest Developments
11.12 Prometheon Pharma (USA)
11.12.1 Prometheon Pharma (USA) Company Information
11.12.2 Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.12.3 Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Prometheon Pharma (USA) Main Business Overview
11.12.5 Prometheon Pharma (USA) Latest Developments
11.13 Ligand Pharma (USA)
11.13.1 Ligand Pharma (USA) Company Information
11.13.2 Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.13.3 Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Ligand Pharma (USA) Main Business Overview
11.13.5 Ligand Pharma (USA) Latest Developments
11.14 Valenta Pharm (Russia)
11.14.1 Valenta Pharm (Russia) Company Information
11.14.2 Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.14.3 Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Valenta Pharm (Russia) Main Business Overview
11.14.5 Valenta Pharm (Russia) Latest Developments
11.15 Lycera Corp (US)
11.15.1 Lycera Corp (US) Company Information
11.15.2 Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.15.3 Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Lycera Corp (US) Main Business Overview
11.15.5 Lycera Corp (US) Latest Developments
11.16 Archimedes (UK)
11.16.1 Archimedes (UK) Company Information
11.16.2 Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.16.3 Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Archimedes (UK) Main Business Overview
11.16.5 Archimedes (UK) Latest Developments
11.17 GMP Endotherapeutics (USA)
11.17.1 GMP Endotherapeutics (USA) Company Information
11.17.2 GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.17.3 GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 GMP Endotherapeutics (USA) Main Business Overview
11.17.5 GMP Endotherapeutics (USA) Latest Developments
11.18 Nuvo Pharmaceuticals (Canada)
11.18.1 Nuvo Pharmaceuticals (Canada) Company Information
11.18.2 Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Product Offered
11.18.3 Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Nuvo Pharmaceuticals (Canada) Main Business Overview
11.18.5 Nuvo Pharmaceuticals (Canada) Latest Developments
11.19 Beijing Wansheng Pharmaceutical
11.19.1 Beijing Wansheng Pharmaceutical Company Information
11.19.2 Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product Offered
11.19.3 Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Beijing Wansheng Pharmaceutical Main Business Overview
11.19.5 Beijing Wansheng Pharmaceutical Latest Developments
11.20 Zhejiang Huahai Pharmaceutical
11.20.1 Zhejiang Huahai Pharmaceutical Company Information
11.20.2 Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product Offered
11.20.3 Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Zhejiang Huahai Pharmaceutical Main Business Overview
11.20.5 Zhejiang Huahai Pharmaceutical Latest Developments
11.21 Zhejiang Jianfeng Pharmaceutical
11.21.1 Zhejiang Jianfeng Pharmaceutical Company Information
11.21.2 Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product Offered
11.21.3 Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Zhejiang Jianfeng Pharmaceutical Main Business Overview
11.21.5 Zhejiang Jianfeng Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Post-Traumatic Stress Disorder (PTSD) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Post-Traumatic Stress Disorder (PTSD) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Cognitive Therapy
Table 4. Major Players of Exposure Therapy
Table 5. Major Players of Eye Movement Desensitization And Reprocessing (EMDR)
Table 6. Major Players of Antidepressants
Table 7. Major Players of Anti-Anxiety Medications
Table 8. Major Players of Prazosin
Table 9. Post-Traumatic Stress Disorder (PTSD) Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025) & ($ millions)
Table 11. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2020-2025)
Table 12. Post-Traumatic Stress Disorder (PTSD) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025) & ($ millions)
Table 14. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2020-2025)
Table 15. Global Post-Traumatic Stress Disorder (PTSD) Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Player (2020-2025)
Table 17. Post-Traumatic Stress Disorder (PTSD) Key Players Head office and Products Offered
Table 18. Post-Traumatic Stress Disorder (PTSD) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Region (2020-2025)
Table 23. Global Post-Traumatic Stress Disorder (PTSD) Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Country (2020-2025)
Table 27. Americas Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2020-2025)
Table 29. Americas Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2020-2025)
Table 31. APAC Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Region (2020-2025)
Table 33. APAC Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Country (2020-2025)
Table 37. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Post-Traumatic Stress Disorder (PTSD)
Table 43. Key Market Challenges & Risks of Post-Traumatic Stress Disorder (PTSD)
Table 44. Key Industry Trends of Post-Traumatic Stress Disorder (PTSD)
Table 45. Global Post-Traumatic Stress Disorder (PTSD) Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global Post-Traumatic Stress Disorder (PTSD) Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global Post-Traumatic Stress Disorder (PTSD) Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. GlaxoSmithKline (UK) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 50. GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 51. GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. GlaxoSmithKline (UK) Main Business
Table 53. GlaxoSmithKline (UK) Latest Developments
Table 54. Pfizer (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 55. Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 56. Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Pfizer (US) Main Business
Table 58. Pfizer (US) Latest Developments
Table 59. Eli Lilly and Company (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 60. Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 61. Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Eli Lilly and Company (US) Main Business
Table 63. Eli Lilly and Company (US) Latest Developments
Table 64. Lundbeck A/S (Denmark) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 65. Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 66. Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Lundbeck A/S (Denmark) Main Business
Table 68. Lundbeck A/S (Denmark) Latest Developments
Table 69. Azevan Pharmaceuticals (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 70. Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 71. Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Azevan Pharmaceuticals (US) Main Business
Table 73. Azevan Pharmaceuticals (US) Latest Developments
Table 74. Marinus Pharmaceuticals, Inc. (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 75. Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 76. Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Marinus Pharmaceuticals, Inc. (US) Main Business
Table 78. Marinus Pharmaceuticals, Inc. (US) Latest Developments
Table 79. Tonix Pharmaceuticals Holding Corp. (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 80. Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 81. Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Tonix Pharmaceuticals Holding Corp. (US) Main Business
Table 83. Tonix Pharmaceuticals Holding Corp. (US) Latest Developments
Table 84. Bionomics (Australia) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 85. Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 86. Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Bionomics (Australia) Main Business
Table 88. Bionomics (Australia) Latest Developments
Table 89. Greenstone LLC (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 90. Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 91. Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Greenstone LLC (US) Main Business
Table 93. Greenstone LLC (US) Latest Developments
Table 94. Mylan NV (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 95. Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 96. Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Mylan NV (US) Main Business
Table 98. Mylan NV (US) Latest Developments
Table 99. Otsuka Pharmaceutical (Japan) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 100. Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 101. Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. Otsuka Pharmaceutical (Japan) Main Business
Table 103. Otsuka Pharmaceutical (Japan) Latest Developments
Table 104. Prometheon Pharma (USA) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 105. Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 106. Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. Prometheon Pharma (USA) Main Business
Table 108. Prometheon Pharma (USA) Latest Developments
Table 109. Ligand Pharma (USA) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 110. Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 111. Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 112. Ligand Pharma (USA) Main Business
Table 113. Ligand Pharma (USA) Latest Developments
Table 114. Valenta Pharm (Russia) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 115. Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 116. Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 117. Valenta Pharm (Russia) Main Business
Table 118. Valenta Pharm (Russia) Latest Developments
Table 119. Lycera Corp (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 120. Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 121. Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 122. Lycera Corp (US) Main Business
Table 123. Lycera Corp (US) Latest Developments
Table 124. Archimedes (UK) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 125. Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 126. Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 127. Archimedes (UK) Main Business
Table 128. Archimedes (UK) Latest Developments
Table 129. GMP Endotherapeutics (USA) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 130. GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 131. GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 132. GMP Endotherapeutics (USA) Main Business
Table 133. GMP Endotherapeutics (USA) Latest Developments
Table 134. Nuvo Pharmaceuticals (Canada) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 135. Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 136. Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 137. Nuvo Pharmaceuticals (Canada) Main Business
Table 138. Nuvo Pharmaceuticals (Canada) Latest Developments
Table 139. Beijing Wansheng Pharmaceutical Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 140. Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 141. Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 142. Beijing Wansheng Pharmaceutical Main Business
Table 143. Beijing Wansheng Pharmaceutical Latest Developments
Table 144. Zhejiang Huahai Pharmaceutical Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 145. Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 146. Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 147. Zhejiang Huahai Pharmaceutical Main Business
Table 148. Zhejiang Huahai Pharmaceutical Latest Developments
Table 149. Zhejiang Jianfeng Pharmaceutical Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 150. Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 151. Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 152. Zhejiang Jianfeng Pharmaceutical Main Business
Table 153. Zhejiang Jianfeng Pharmaceutical Latest Developments
Table 1. Post-Traumatic Stress Disorder (PTSD) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Post-Traumatic Stress Disorder (PTSD) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Cognitive Therapy
Table 4. Major Players of Exposure Therapy
Table 5. Major Players of Eye Movement Desensitization And Reprocessing (EMDR)
Table 6. Major Players of Antidepressants
Table 7. Major Players of Anti-Anxiety Medications
Table 8. Major Players of Prazosin
Table 9. Post-Traumatic Stress Disorder (PTSD) Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025) & ($ millions)
Table 11. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2020-2025)
Table 12. Post-Traumatic Stress Disorder (PTSD) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025) & ($ millions)
Table 14. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2020-2025)
Table 15. Global Post-Traumatic Stress Disorder (PTSD) Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Player (2020-2025)
Table 17. Post-Traumatic Stress Disorder (PTSD) Key Players Head office and Products Offered
Table 18. Post-Traumatic Stress Disorder (PTSD) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Region (2020-2025)
Table 23. Global Post-Traumatic Stress Disorder (PTSD) Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Country (2020-2025)
Table 27. Americas Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2020-2025)
Table 29. Americas Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2020-2025)
Table 31. APAC Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Region (2020-2025)
Table 33. APAC Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Country (2020-2025)
Table 37. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Post-Traumatic Stress Disorder (PTSD)
Table 43. Key Market Challenges & Risks of Post-Traumatic Stress Disorder (PTSD)
Table 44. Key Industry Trends of Post-Traumatic Stress Disorder (PTSD)
Table 45. Global Post-Traumatic Stress Disorder (PTSD) Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global Post-Traumatic Stress Disorder (PTSD) Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global Post-Traumatic Stress Disorder (PTSD) Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. GlaxoSmithKline (UK) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 50. GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 51. GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. GlaxoSmithKline (UK) Main Business
Table 53. GlaxoSmithKline (UK) Latest Developments
Table 54. Pfizer (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 55. Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 56. Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Pfizer (US) Main Business
Table 58. Pfizer (US) Latest Developments
Table 59. Eli Lilly and Company (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 60. Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 61. Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Eli Lilly and Company (US) Main Business
Table 63. Eli Lilly and Company (US) Latest Developments
Table 64. Lundbeck A/S (Denmark) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 65. Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 66. Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Lundbeck A/S (Denmark) Main Business
Table 68. Lundbeck A/S (Denmark) Latest Developments
Table 69. Azevan Pharmaceuticals (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 70. Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 71. Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Azevan Pharmaceuticals (US) Main Business
Table 73. Azevan Pharmaceuticals (US) Latest Developments
Table 74. Marinus Pharmaceuticals, Inc. (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 75. Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 76. Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Marinus Pharmaceuticals, Inc. (US) Main Business
Table 78. Marinus Pharmaceuticals, Inc. (US) Latest Developments
Table 79. Tonix Pharmaceuticals Holding Corp. (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 80. Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 81. Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Tonix Pharmaceuticals Holding Corp. (US) Main Business
Table 83. Tonix Pharmaceuticals Holding Corp. (US) Latest Developments
Table 84. Bionomics (Australia) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 85. Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 86. Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Bionomics (Australia) Main Business
Table 88. Bionomics (Australia) Latest Developments
Table 89. Greenstone LLC (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 90. Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 91. Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Greenstone LLC (US) Main Business
Table 93. Greenstone LLC (US) Latest Developments
Table 94. Mylan NV (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 95. Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 96. Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Mylan NV (US) Main Business
Table 98. Mylan NV (US) Latest Developments
Table 99. Otsuka Pharmaceutical (Japan) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 100. Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 101. Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. Otsuka Pharmaceutical (Japan) Main Business
Table 103. Otsuka Pharmaceutical (Japan) Latest Developments
Table 104. Prometheon Pharma (USA) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 105. Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 106. Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. Prometheon Pharma (USA) Main Business
Table 108. Prometheon Pharma (USA) Latest Developments
Table 109. Ligand Pharma (USA) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 110. Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 111. Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 112. Ligand Pharma (USA) Main Business
Table 113. Ligand Pharma (USA) Latest Developments
Table 114. Valenta Pharm (Russia) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 115. Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 116. Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 117. Valenta Pharm (Russia) Main Business
Table 118. Valenta Pharm (Russia) Latest Developments
Table 119. Lycera Corp (US) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 120. Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 121. Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 122. Lycera Corp (US) Main Business
Table 123. Lycera Corp (US) Latest Developments
Table 124. Archimedes (UK) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 125. Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 126. Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 127. Archimedes (UK) Main Business
Table 128. Archimedes (UK) Latest Developments
Table 129. GMP Endotherapeutics (USA) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 130. GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 131. GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 132. GMP Endotherapeutics (USA) Main Business
Table 133. GMP Endotherapeutics (USA) Latest Developments
Table 134. Nuvo Pharmaceuticals (Canada) Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 135. Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 136. Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 137. Nuvo Pharmaceuticals (Canada) Main Business
Table 138. Nuvo Pharmaceuticals (Canada) Latest Developments
Table 139. Beijing Wansheng Pharmaceutical Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 140. Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 141. Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 142. Beijing Wansheng Pharmaceutical Main Business
Table 143. Beijing Wansheng Pharmaceutical Latest Developments
Table 144. Zhejiang Huahai Pharmaceutical Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 145. Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 146. Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 147. Zhejiang Huahai Pharmaceutical Main Business
Table 148. Zhejiang Huahai Pharmaceutical Latest Developments
Table 149. Zhejiang Jianfeng Pharmaceutical Details, Company Type, Post-Traumatic Stress Disorder (PTSD) Area Served and Its Competitors
Table 150. Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product Offered
Table 151. Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 152. Zhejiang Jianfeng Pharmaceutical Main Business
Table 153. Zhejiang Jianfeng Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Post-Traumatic Stress Disorder (PTSD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Post-Traumatic Stress Disorder (PTSD) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Post-Traumatic Stress Disorder (PTSD) Sales Market Share by Country/Region (2024)
Figure 8. Post-Traumatic Stress Disorder (PTSD) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type in 2024
Figure 10. Post-Traumatic Stress Disorder (PTSD) in Children
Figure 11. Global Post-Traumatic Stress Disorder (PTSD) Market: Children (2020-2025) & ($ millions)
Figure 12. Post-Traumatic Stress Disorder (PTSD) in Adult
Figure 13. Global Post-Traumatic Stress Disorder (PTSD) Market: Adult (2020-2025) & ($ millions)
Figure 14. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application in 2024
Figure 15. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Player in 2024
Figure 16. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Region (2020-2025)
Figure 17. Americas Post-Traumatic Stress Disorder (PTSD) Market Size 2020-2025 ($ millions)
Figure 18. APAC Post-Traumatic Stress Disorder (PTSD) Market Size 2020-2025 ($ millions)
Figure 19. Europe Post-Traumatic Stress Disorder (PTSD) Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size 2020-2025 ($ millions)
Figure 21. Americas Post-Traumatic Stress Disorder (PTSD) Value Market Share by Country in 2024
Figure 22. United States Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Region in 2024
Figure 27. APAC Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2020-2025)
Figure 28. APAC Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2020-2025)
Figure 29. China Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 33. India Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Country in 2024
Figure 36. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2020-2025)
Figure 37. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2020-2025)
Figure 38. Germany Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 39. France Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 52. APAC Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 53. Europe Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 55. United States Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 56. Canada Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 57. Mexico Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 58. Brazil Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 59. China Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 60. Japan Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 61. Korea Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 63. India Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 64. Australia Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 65. Germany Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 66. France Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 67. UK Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 68. Italy Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 69. Russia Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 70. Egypt Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 71. South Africa Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 72. Israel Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 73. Turkey Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 74. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 1. Post-Traumatic Stress Disorder (PTSD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Post-Traumatic Stress Disorder (PTSD) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Post-Traumatic Stress Disorder (PTSD) Sales Market Share by Country/Region (2024)
Figure 8. Post-Traumatic Stress Disorder (PTSD) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type in 2024
Figure 10. Post-Traumatic Stress Disorder (PTSD) in Children
Figure 11. Global Post-Traumatic Stress Disorder (PTSD) Market: Children (2020-2025) & ($ millions)
Figure 12. Post-Traumatic Stress Disorder (PTSD) in Adult
Figure 13. Global Post-Traumatic Stress Disorder (PTSD) Market: Adult (2020-2025) & ($ millions)
Figure 14. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application in 2024
Figure 15. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Player in 2024
Figure 16. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Region (2020-2025)
Figure 17. Americas Post-Traumatic Stress Disorder (PTSD) Market Size 2020-2025 ($ millions)
Figure 18. APAC Post-Traumatic Stress Disorder (PTSD) Market Size 2020-2025 ($ millions)
Figure 19. Europe Post-Traumatic Stress Disorder (PTSD) Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size 2020-2025 ($ millions)
Figure 21. Americas Post-Traumatic Stress Disorder (PTSD) Value Market Share by Country in 2024
Figure 22. United States Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Region in 2024
Figure 27. APAC Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2020-2025)
Figure 28. APAC Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2020-2025)
Figure 29. China Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 33. India Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Country in 2024
Figure 36. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2020-2025)
Figure 37. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2020-2025)
Figure 38. Germany Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 39. France Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Post-Traumatic Stress Disorder (PTSD) Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 52. APAC Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 53. Europe Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 55. United States Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 56. Canada Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 57. Mexico Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 58. Brazil Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 59. China Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 60. Japan Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 61. Korea Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 63. India Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 64. Australia Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 65. Germany Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 66. France Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 67. UK Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 68. Italy Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 69. Russia Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 70. Egypt Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 71. South Africa Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 72. Israel Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 73. Turkey Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
Figure 74. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Post-Traumatic Stress Disorder (PTSD) Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Post-Traumatic Stress Disorder (PTSD) Market Size 2026-2031 ($ millions)
More Publications
Global Vitamin B6 Market Growth 2025-2031
US$ 3,660.00
December 2024
80 pages
Global Temporary Cardiac Pacing Leads Market Growth 2025-2031
US$ 3,660.00
January 2025
89 pages
Global Prosthetic Liners Market Growth 2025-2031
US$ 3,660.00
December 2024
109 pages
Global Vancomycin Market Growth 2023-2029
US$ 3,660.00
March 2023
128 pages
Global Lipoic Acid Market Growth 2025-2031
US$ 3,660.00
December 2024
105 pages
